Literature DB >> 24156825

FFPE tissue as a feasible source for gene expression analysis--a comparison of three reference genes and one tumor marker.

Robert Fred Henry Walter1, Fabian Dominik Mairinger, Jeremias Wohlschlaeger, Karl Worm, Saskia Ting, Claudia Vollbrecht, Kurt Werner Schmid, Thomas Hager.   

Abstract

BACKGROUND: Formalin-fixation, paraffin-embedding is the standard processing technique for tumor tissue in modern pathology. New techniques such as cryo-conservation allow rapid fixation and long-time storage but come along with increased costs and enlarged storage complexity. However, formalin-fixed, paraffin-embedded (FFPE) tissue is available in a large quantity, making it the ideal material for retrospective studies. The following study was designed to investigate the influence of formalin-fixation on the quality of mRNA and applicability of FFPE-derived mRNA for gene expression analysis. Three potential reference genes for pulmonary tumors with neuroendocrine differentiation were included and tested for their robust expression.
MATERIALS AND METHODS: Eighty specimens collected from 2005 to 2012 at the Institute of Pathology and Neuropathology at the University Hospital Essen were analyzed for their gene expression by using TaqMan(®) gene expression assays on demand (AoD). Three distinct potential reference genes (ACTB, GAPDH, HPRT1) were evaluated for their expression, and a proteasome subunit (PSMA1) was included in the analysis as tumor marker and functioned as an internal technical control.
CONCLUSION: For GAPDH and ACTB, a highly significant correlation and consistent expression between the investigated entities was found, making them reliable reference genes for further research. Additionally, the feasibility for a FFPE tissue-based gene expression analysis was verified by showing that the mRNA quality is sufficient. When standardized FFPE preparation is performed carefully, sufficient mRNA can be isolated for reliable and successful gene expression analysis. That provides the basis the door for large, retrospective studies that correlate molecular and clinical follow-up data.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  ACTB; AoD; CT; FFPE; GAPDH; HE; HPRT1; IHC; LCLC; NTC; Neuroendocrine cancer; PSMA1; Pulmonary cancer; RNA quality; Reference genes; SCLC; actin, beta; assay on demand; formalin-fixed, paraffin-embedded; glyceraldehyde-3-phosphate dehydrogenase; hematoxylin and eosin; hypoxanthine phosphoribosyltransferase 1; immonhistochemistry; large cell lung cancer; mRNA; messenger ribonucleic acid; non-template control; proteasome (prosome, macropain) subunit, alpha type, 1; qPCR; quantitative polymerase chain reaction; small cell lung cancer; treshhold cycle

Mesh:

Substances:

Year:  2013        PMID: 24156825     DOI: 10.1016/j.prp.2013.09.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  17 in total

1.  Validation of Reference Genes for Expression Studies in Human Meningiomas under Different Experimental Settings.

Authors:  Diana Freitag; Arend Koch; Aaron Lawson McLean; Rolf Kalff; Jan Walter
Journal:  Mol Neurobiol       Date:  2017-10-27       Impact factor: 5.590

2.  The importance of reference gene analysis of formalin-fixed, paraffin-embedded samples from sarcoma patients - an often underestimated problem.

Authors:  Ninna Aggerholm-Pedersen; Akmal Safwat; Steen Bærentzen; Marianne Nordsmark; Ole Steen Nielsen; Jan Alsner; Brita S Sørensen
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

3.  MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.

Authors:  R F H Walter; F D Mairinger; S Ting; C Vollbrecht; T Mairinger; D Theegarten; D C Christoph; K W Schmid; J Wohlschlaeger
Journal:  Br J Cancer       Date:  2015-02-10       Impact factor: 7.640

4.  Identification of reference proteins for Western blot analyses in mouse model systems of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) toxicity.

Authors:  Stephenie D Prokopec; John D Watson; Raimo Pohjanvirta; Paul C Boutros
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

Review 5.  Emerging understanding of multiscale tumor heterogeneity.

Authors:  Michael J Gerdes; Anup Sood; Christopher Sevinsky; Andrew D Pris; Maria I Zavodszky; Fiona Ginty
Journal:  Front Oncol       Date:  2014-12-18       Impact factor: 6.244

6.  Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis.

Authors:  Robert Fred Henry Walter; Robert Werner; Saskia Ting; Claudia Vollbrecht; Dirk Theegarten; Daniel Christian Christoph; Kurt Werner Schmid; Jeremias Wohlschlaeger; Fabian Dominik Mairinger
Journal:  Oncotarget       Date:  2015-09-22

7.  ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.

Authors:  Robert Fred Henry Walter; Robert Werner; Claudia Vollbrecht; Thomas Hager; Elena Flom; Daniel Christian Christoph; Jan Schmeller; Kurt Werner Schmid; Jeremias Wohlschlaeger; Fabian Dominik Mairinger
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

8.  Comparing gene expression data from formalin-fixed, paraffin embedded tissues and qPCR with that from snap-frozen tissue and microarrays for modeling outcomes of patients with ovarian carcinoma.

Authors:  William H Bradley; Kevin Eng; Min Le; A Craig Mackinnon; Christina Kendziorski; Janet S Rader
Journal:  BMC Clin Pathol       Date:  2015-09-24

9.  Quantitative analysis of gene expression in fixed colorectal carcinoma samples as a method for biomarker validation.

Authors:  Beata Ostasiewicz; Paweł Ostasiewicz; Kamila Duś-Szachniewicz; Katarzyna Ostasiewicz; Piotr Ziółkowski
Journal:  Mol Med Rep       Date:  2016-04-27       Impact factor: 2.952

10.  Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome.

Authors:  Robert Fred Henry Walter; Fabian Dominik Mairinger; Robert Werner; Claudia Vollbrecht; Thomas Hager; Kurt Werner Schmid; Jeremias Wohlschlaeger; Daniel Christian Christoph
Journal:  Oncotarget       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.